Center for Translational Antiviral Research Reports Novel Drug Class with Activity Against SARS-CoV-2 The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses such as respiratory syncytial virus (RSV) in children has caused an urgent need for the development of orally available broad-spectrum antiviral therapeutics. In a study published online on December 2,…
